Advertisement

Permanent-Implant Brachytherapy in Prostate Cancer

  • Marco Zaider
Part of the Medical Radiology book series (MEDRAD)

Keywords

Radiat Oncol Biol Phys Localize Prostate Cancer Computerize Tomog Magnetic Resonance Spectroscopic Imaging Tumor Control Probability 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abbas F, Scardino PT (1997) The natural history of clinical prostate carcinoma. Cancer 80:827–833PubMedCrossRefGoogle Scholar
  2. Albertsen PC, Hanley JA, Gleason DF, Barry MJ (1998) Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. J Am Med Assoc 280:975–980CrossRefGoogle Scholar
  3. Amols HI, Zaider M, Hayes MK, Schiff PB (1997) Physician/ patient-driven risk assignment in radiation oncology: Reality or fancy? Int J Radiat Oncol Biol Phys 38:455–461PubMedCrossRefGoogle Scholar
  4. Brahme A (2001) Individualizing cancer treatment: biological optimization models in treatment planning and delivery. Int J Radiat Oncol Biol Phys 49:327–337PubMedCrossRefGoogle Scholar
  5. Brahme A, Nilsson J, Belkic D (2001) Biologically optimized radiation therapy. Acta Oncol 40:725–734PubMedCrossRefGoogle Scholar
  6. Chambers L (1995) Practical handbook of genetic algorithms. CRC Press, Boca Raton, FloridaGoogle Scholar
  7. Chodak GW (1998) Comparing treatments for localized prostate cancer-persisting uncertainty. J Am Med Assoc 280:1008–1010CrossRefGoogle Scholar
  8. Cohen GN, Amols HI, Zelefsky MJ, Zaider M (2002) The Anderson nomograms for permanent interstitial prostate implants: a briefing for practitioners. Int J Radiat Oncol Biol Phys 53:504–511PubMedCrossRefGoogle Scholar
  9. Critz FA, Williams WH, Levinson AK, Benton JB, Holladay CT, Schnell FJ (2000) Simultaneous irradiation for prostate cancer: intermediate results with modern techniques. J Urol 164:738–741PubMedGoogle Scholar
  10. D’souza WD, Thames HD, Kuban DA (2004) Dose-volume conundrum for response of prostate cancer to brachytherapy: summary of dosimetric measures and their relationship to tumor control probability. Int J Radiat Oncol Biol Phys 58:1540–1548PubMedGoogle Scholar
  11. Fowler JF (1989) The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62:679–694PubMedGoogle Scholar
  12. Gallagher RJ, Lee EK (1997) Mixed integer programming optimization models for brachytherapy treatment planning. Proc MIA Annual Fall Symposium, pp 278–282Google Scholar
  13. Grefenstette JJ, American Association for Artificial Intelligence, Bolt BaNi, Naval Research Laboratory (U.S.) (1987) Genetic algorithms and their applications. Proc Second International Conference on Genetic Algorithms, 28–31 July 1987, Massachusetts Institute of Technology, Cambridge, Massachusetts. Erlbaum, Hillsdale, New JerseyGoogle Scholar
  14. Haworth A, Ebert M, Waterhouse D, Joseph D, Duchesne G (2004a) Assessment of I-125 prostate implants by tumor bioeffect. Int J Radiat Oncol Biol Phys 59:1405–1413PubMedCrossRefGoogle Scholar
  15. Haworth A, Ebert M, Waterhouse D, Joseph D, Duchesne G (2004b) Prostate implant evaluation using tumour control probability: the effect of input parameters. Phys Med Biol 49:3649–3664PubMedCrossRefGoogle Scholar
  16. Jani AB, Hellman S (2003) Early prostate cancer: clinical decision-making. Lancet 361:1045–1053PubMedCrossRefGoogle Scholar
  17. King CR, DiPetrillo TA, Wazer DE (2000) Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models. Int J Radiat Oncol Biol Phys 46:165–172PubMedCrossRefGoogle Scholar
  18. Kurhanewicz J, Vigneron DB, Nelson SJ, Hricak H, MacDonald JM, Konety B, Narayan P (1995) Ctrate as an in-vivo marker to discriminate prostate-cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology 45:459–466PubMedCrossRefGoogle Scholar
  19. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ (1996) Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24–0.1 cm3) spatial resolution. Radiology 198:795–805PubMedGoogle Scholar
  20. Kurhanewicz J, Vigneron DB, Males RG, Swanson MG, Yu KK, Hricak H (2000a) The prostate: MR imaging and spectroscopy-present and future. Radiol Clin North Am 38:115PubMedCrossRefGoogle Scholar
  21. Kurhanewicz J, Vigneron DB, Nelson SJ (2000b) Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia 2:166–189PubMedCrossRefGoogle Scholar
  22. Lee EK, Zaider M (2001) On the determination of an effective planning volume for permanent prostate implants. Int J Radiat Oncol Biol Phys 49:1197–1206PubMedGoogle Scholar
  23. Lee EK, Gallagher RJ, Silvern D, Wuu CS, Zaider M (1999) Treatment planning for brachytherapy: an integer programming model, two computational approaches and experiments with permanent prostate implant planning. Phys Med Biol 44:145–165PubMedCrossRefGoogle Scholar
  24. Lee SP, Leu MY, Smathers JB, McBride WH, Parker RG, Withers HR (1995) Biologically effective dose distribution based on the linear-quadratic model and its clinical relevance. Int J Radiat Oncol Biol Phys 33:375–389PubMedCrossRefGoogle Scholar
  25. MacKay RI, Hendry JH, Moore CJ, Williams PC, Read G (1997) Predicting late rectal complications following prostate conformal radiotherapy using biologically effective doses and normalized dose-surface histograms. Br J Radiol 70:517–526PubMedGoogle Scholar
  26. Man KF, Tang KS, Kwong S (1999) Genetic algorithms concepts and designs. Springer, Berlin Heidelberg, New YorkGoogle Scholar
  27. McGregor M, Hanley JA, Boivin JF, Mclean RG (1998) Screening for prostate cancer: estimating the magnitude of overdetection. Can Med Assoc J 159:1368–1372Google Scholar
  28. Mizowaki T, Cohen G, Fung AYC, Zaider M (2002) Towards integrating functional imaging in the treatment of prostate cancer with radiation: the registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planning. Int J Radiat Oncol Biol Phys 54:1558–1564PubMedGoogle Scholar
  29. Nag S, Shasha D, Janjan N, Petersen I, Zaider M (2001) The American Brachytherapy Society recommendations for brachytherapy of soft tissue sarcomas. Int J Radiat Oncol Biol Phys 49:1033–1043PubMedCrossRefGoogle Scholar
  30. Peschel RE, Colberg JW (2003) Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer. Lancet Oncol 4:233–241PubMedCrossRefGoogle Scholar
  31. Pouliot J, Tremblay D, Roy J, Filice S (1996) Optimization of permanent I-125 prostate implants using fast simulated annealing. Int J Radiat Oncol Biol Phys 36:711–720PubMedCrossRefGoogle Scholar
  32. Sandhu AS, Zelefsky MJ, Lee HJ, Lombardi D, Fuks Z, Leibel SA (2000) Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection. Int J Radiat Oncol Biol Phys 48:643–647PubMedGoogle Scholar
  33. Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, Zaloudek CJ, Nelson SJ, Carroll PR, Kurhanewicz J (1999) Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 213:473–480PubMedGoogle Scholar
  34. Silvern DA (1998) Automated OR prostate brachytherapy treatment planning using genetic optimization. Thesis, Columbia University, New YorkGoogle Scholar
  35. Sloboda RS (1992) Optimization of brachytherapy dose distribution by simulated annealing. Med Phys 19:964CrossRefGoogle Scholar
  36. Todor DA, Cohen GN, Amols HI, Zaider M (2002a) Operator-free, film-based 3D seed reconstruction in brachytherapy. Phys Med Biol 47:2031–2048PubMedCrossRefGoogle Scholar
  37. Todor DA, Cohen GN, Amols HI, Zaider M (2002b) Operator-free, film-based 3D seed reconstruction in brachytherapy. Phys Med Biol 47:2031–2048PubMedCrossRefGoogle Scholar
  38. Todor DA, Zaider M, Cohen GN, Worman MF, Zelefsky MJ (2003) Intraoperative dynamic dosimetry for prostate implants. Phys Med Biol 48:1153–1171PubMedCrossRefGoogle Scholar
  39. Tubic D, Zaccarin A, Pouliot J, Beaulieu L (2001) Automated seed detection and three-dimensional reconstruction. I. Seed localization from fluoroscopic images or radiographs. Med Phys 28:2265–2271PubMedGoogle Scholar
  40. Wang JZ, Li XA (2003) Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose. Med Phys 30:34–40PubMedGoogle Scholar
  41. Waterman FM, Yue N, Corn BW, Dicker AP (1997) Edema associated with I-125 or Pd-103 prostate brachytherapy and its effect on post-implant dosimetry: an analysis based on serial CT acquisition. Int J Radiat Oncol Biol Phys 39:220CrossRefGoogle Scholar
  42. Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu Y, Wefer J, Mueller-Lisse U, Carroll PR, Kurhanewicz J (2000) Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 164:400–404PubMedCrossRefGoogle Scholar
  43. Zaider M, Minerbo GN (2000) Tumour control probability: a formulation applicable to any temporal protocol of dose delivery. Phys Med Biol 45:279–293PubMedCrossRefGoogle Scholar
  44. Zaider M, Zelefsky MJ, Lee EK, Zakian KL, Amols HI, Dyke J, Cohen G, Hu Y, Endi AK, Chui C, Koutcher JA (2000) Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys 47:1085–1096PubMedCrossRefGoogle Scholar
  45. Zaider M, Zelefsky M, Cohen AM, Chui C, Yorke ED, Ben-Porat L, Happersett MA (2005) Methodology for biologically based treatment planning for combined low dose-rate (permanent implant) and high dose-rate (fractionated) treatment of prostate cancer. Int J Radiat Oncol Biol Phys 61:702–713PubMedCrossRefGoogle Scholar
  46. Zalzala AMS, Fleming PJ (1997) Genetic algorithms in engineering systems. Institution of Electrical Engineers, LondonGoogle Scholar
  47. Zelefsky MJ, Hollister T, Raben A, Matthews S, Wallner KE (2000a) Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 47:1261–1266PubMedCrossRefGoogle Scholar
  48. Zelefsky MJ, Cohen G, Zakian KL, Dyke J, Koutcher JA, Hricak H, Schwartz L, Zaider M (2000b) Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging. Cancer J 6:249–255PubMedGoogle Scholar
  49. Zhang M, Zaider M, Worman M, Cohen G (2004) On the question of 3D seed reconstruction in prostate brachytherapy: the determination of X-ray source and film locations. Phys Med Biol 49:N335–N345PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2006

Authors and Affiliations

  • Marco Zaider
    • 1
  1. 1.Department of Medical PhysicsMemorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations